MX2017012019A - Composicion antitranspirante. - Google Patents
Composicion antitranspirante.Info
- Publication number
- MX2017012019A MX2017012019A MX2017012019A MX2017012019A MX2017012019A MX 2017012019 A MX2017012019 A MX 2017012019A MX 2017012019 A MX2017012019 A MX 2017012019A MX 2017012019 A MX2017012019 A MX 2017012019A MX 2017012019 A MX2017012019 A MX 2017012019A
- Authority
- MX
- Mexico
- Prior art keywords
- antiperspirant composition
- specified protein
- composition
- reducing
- orai3
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un método para reducir la transpiración que comprende la aplicación tópica de una composición que comprende un siRNA que es capaz de reducir los niveles de una proteína especificada o su mRNA o la función o formación del canal de calcio asociado con este; en donde la proteína especificada es Orai1, Stim1, Orai3, TRPC1 o Stim2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15160174 | 2015-03-20 | ||
PCT/EP2016/055157 WO2016150723A1 (en) | 2015-03-20 | 2016-03-10 | Antiperspirant composition |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2017012019A true MX2017012019A (es) | 2018-01-30 |
MX367563B MX367563B (es) | 2019-08-27 |
Family
ID=52686284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017012019A MX367563B (es) | 2015-03-20 | 2016-03-10 | Composición antitranspirante. |
Country Status (6)
Country | Link |
---|---|
US (1) | US10227594B2 (es) |
EP (1) | EP3270881B1 (es) |
AU (1) | AU2016236521B2 (es) |
BR (1) | BR112017018029B1 (es) |
MX (1) | MX367563B (es) |
WO (1) | WO2016150723A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3084824A1 (en) | 2017-12-15 | 2019-06-20 | Flagship Pioneering Innovations Vi, Llc | Compositions comprising circular polyribonucleotides and uses thereof |
CA3128644A1 (en) * | 2019-03-01 | 2020-09-10 | Avak Kahvejian | Polyribonucleotides and cosmetic uses thereof |
EP4351739A2 (en) | 2021-06-07 | 2024-04-17 | Unilever IP Holdings B.V. | Compositions and methods for controlling sweat production |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2797447B1 (fr) | 1999-08-12 | 2004-04-02 | Univ Clermont Auvergne | "odorant-binding" proteines humaines fixant des ligands hydrophobes:polypeptides et polynucleotides codant lesdits polypeptides et leurs applications |
FR2804960B1 (fr) | 2000-02-11 | 2005-06-24 | Lvmh Rech | Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants |
GB0019055D0 (en) | 2000-08-03 | 2000-09-27 | Unilever Plc | Antiperspirant and deodorant products and methods for their use |
FR2840217B1 (fr) | 2002-06-03 | 2005-06-24 | Oreal | Compositions cosmetiques comprenant au moins un oligonucleotide d'arn double brin (dsrna)et leurs utilisations |
PT2284266E (pt) | 2002-11-14 | 2013-12-17 | Thermo Fisher Scient Biosciences Inc | Siarn contra tp53 |
US7504385B2 (en) | 2003-12-17 | 2009-03-17 | Avon Products, Inc. | si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
DE102004010547A1 (de) | 2004-03-03 | 2005-11-17 | Beiersdorf Ag | Oligoribonukleotide zur Behandlung von irritativen und/oder entzündlichen Hauterscheinungen durch RNA-Interferenz |
JPWO2005116204A1 (ja) | 2004-05-11 | 2008-06-19 | 株式会社アルファジェン | Rna干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法 |
EP1814996A2 (en) | 2004-11-19 | 2007-08-08 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
DE102005001784A1 (de) | 2005-01-13 | 2006-10-05 | Beiersdorf Ag | Oligoribonukleotide zur Reduktion der Schweißbildung durch RNA-Interferenz |
US7534762B2 (en) | 2005-03-18 | 2009-05-19 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
FR2890859B1 (fr) | 2005-09-21 | 2012-12-21 | Oreal | Oligonucleotide d'arn double brin inhibant l'expression de la tyrosinase |
WO2007046102A2 (en) | 2005-10-19 | 2007-04-26 | Menni Menashe Zinger | Methods for the treatment of hyperhidrosis |
WO2007068735A1 (en) | 2005-12-14 | 2007-06-21 | Novozymes A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
PT2170403E (pt) | 2007-06-27 | 2014-07-17 | Quark Pharmaceuticals Inc | Composições e métodos para inibição da expressão de genes pró-apoptóticos |
US8618160B2 (en) | 2007-10-18 | 2013-12-31 | Rose U | Topical glycopyrrolate formulations |
EP2201113B1 (en) | 2007-10-18 | 2015-09-16 | SNU R & DB Foundation | Method of identifying agents which modulate the activity of calcium-activated chloride channel |
WO2010080452A2 (en) | 2008-12-18 | 2010-07-15 | Quark Pharmaceuticals, Inc. | siRNA COMPOUNDS AND METHODS OF USE THEREOF |
FR2948021A1 (fr) | 2009-07-16 | 2011-01-21 | Oreal | Utilisation cosmetique de polypeptides de type lacritine |
EP2814455B1 (en) | 2012-02-13 | 2017-07-19 | Unilever N.V. | A skin lightening composition |
WO2014027050A1 (en) | 2012-08-16 | 2014-02-20 | Brain Biotechnology Research And Information Network Ag | A novel calcium-activated chloride channel involved in human sweat formation |
JP6242402B2 (ja) | 2013-01-03 | 2017-12-06 | ハイドロス セラピューティクス インターナショナル アクチエボラグ | 多汗症の治療 |
EP2865758A1 (en) * | 2013-10-22 | 2015-04-29 | Sylentis, S.A.U. | siRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene |
-
2016
- 2016-03-10 MX MX2017012019A patent/MX367563B/es active IP Right Grant
- 2016-03-10 EP EP16709080.2A patent/EP3270881B1/en active Active
- 2016-03-10 WO PCT/EP2016/055157 patent/WO2016150723A1/en active Application Filing
- 2016-03-10 US US15/556,462 patent/US10227594B2/en active Active
- 2016-03-10 BR BR112017018029-4A patent/BR112017018029B1/pt active IP Right Grant
- 2016-03-10 AU AU2016236521A patent/AU2016236521B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
MX367563B (es) | 2019-08-27 |
US10227594B2 (en) | 2019-03-12 |
BR112017018029A2 (pt) | 2018-04-10 |
EP3270881A1 (en) | 2018-01-24 |
EP3270881B1 (en) | 2018-12-26 |
WO2016150723A1 (en) | 2016-09-29 |
AU2016236521A1 (en) | 2017-09-07 |
AU2016236521B2 (en) | 2019-03-07 |
BR112017018029B1 (pt) | 2021-06-15 |
US20180037894A1 (en) | 2018-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3730579B8 (en) | Composition containing refrigerant, use of said composition, refrigerator having said composition, and method for operating said refrigerator | |
PH12018500906A1 (en) | Antibodies specifically binding pd-1 and their uses | |
PH12018501159A1 (en) | Composition and methods for immunooncology | |
EP3479506A4 (en) | PROCESS FOR TWO-STAGE PLANNING AT A DOWNLINK CONTROL CHANNEL | |
PH12019501357A1 (en) | Anti-ox40 antibodies and their uses | |
EP3602384A4 (en) | LAYERED MASKING OF CONTENT | |
MX2018010295A (es) | Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos. | |
MX2018013038A (es) | Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos. | |
EP3081546A4 (en) | Rapid-setting and hardening, high-belite sulfoaluminate cement clinker as well as application and production process thereof | |
AU2016263598A8 (en) | Methods and kits for treating depression | |
SG10201902326XA (en) | Mk2 inhibitors and uses thereof | |
MX2021010460A (es) | Metodo de tratamiento con tradipitant. | |
EP3630962A4 (en) | CBLB ENDONUCLEASE VARIANTS, COMPOSITIONS AND METHODS OF USE | |
EA033325B1 (ru) | Ингибиторы бромодомена | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
EP3641888A4 (en) | PLASMINOGEN TREATMENT OF DISEASES RELATED TO PAI-1 OVEREXPRESSION | |
EP3585376A4 (en) | CALCIUM CHANNELS INHIBITORS | |
MX2020009939A (es) | Metodos para tratar el sindrome de prader-willi. | |
EP3644062A4 (en) | METHOD FOR PREDICTING RESPONSE OF SOPHAGE CANCER TO ANTI-ERBB3 ANTIBODY THERAPY, AND KIT | |
MX2020003219A (es) | Anticuerpos que tienen especificidad para btn2 y usos de los mismos. | |
EP3713537A4 (en) | TOPICAL COMPOSITIONS, THEIR MANUFACTURING PROCESS AND THEIR USE OF | |
PH12018500203A1 (en) | Anti-cd154 antibodies and methods of using them | |
EP3312151A4 (en) | Oxidation-induced self-healing ceramic composition containing healing activator, method for producing same, use of same, and method for enhancing functionality of oxidation-induced self-healing ceramic composition | |
MX367563B (es) | Composición antitranspirante. | |
MX2021006326A (es) | Inhibidores de pcna. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |